RGNT - REGENTIS BIOMATERIALS LTD.
3.2471
-0.099 -3.046%
Share volume: 2,716
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$3.35
-0.10
-0.03%
Fundamental analysis
0%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
0%
Performance
5 Days
0.84%
1 Month
-32.49%
3 Months
-56.65%
6 Months
-56.71%
1 Year
-56.71%
2 Year
-56.71%
Key data
Stock price
$3.25
DAY RANGE
$3.20 - $3.32
52 WEEK RANGE
$3.10 - $8.35
52 WEEK CHANGE
-$56.71
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Eli Hazum
Region: US
Website: www.regentis.co.il/
Employees: 10
IPO year: 2025
Issue type:
Market: NYSE American
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Region: US
Website: www.regentis.co.il/
Employees: 10
IPO year: 2025
Issue type:
Market: NYSE American
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
We are a regenerative medicine company dedicated to developing innovative tissue repair solutions that seek to restore the health and enhance the quality of life of patients. Regentis Biomaterials LTD is located in Herzliya, Israel.
Recent news